About Us

CURE Hepatitis C is a quarterly journal and daily news web site that seeks to increase awareness for hepatitis C by highlighting the personal stories of patients and the hope that new treatment options bring.

CURE Media Group, through its unique and award-winning products, has been a source of information and inspiration for patients and families on the cancer journey since 2002. CURE Media Group's flagship product, CURE™ magazine, is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers, CURE is the largest consumer magazine in the United States focused entirely on cancer, with broad distribution to cancer patients, cancer centers, and advocacy groups.

CURE magazine, launched in 2002 for cancer patients, survivors and caregivers, has become the largest consumer magazine in the United States focused entirely on cancer. With a circulation of 300,000 individual subscribers account for over 170,000 of that figure with the remainder going to cancer centers and advocacy groups around the country. Since its inception, CURE has expanded to reflect the entire cancer continuum, including supportive care issues and long-term and late effects.

In 2014, Michael J. Hennessy Associates' Inc (MJH) acquired CURE MEDIA GROUP. In 2015, MJH launched CURE Hepatitis C to share the inspiring stories of patients who have overcome the virus and inspire change that may help eradicate the virus.


Managing Editor, CURE Hepatitis C magazine and web site

Davy James


Director of Business Development

Chris Hennessy

President, Oncology Specialty Group
Mike Hennessy, Jr.

National Accounts Executive

John Dykeman